Spandidos Publications style
Sumitani M, Ogata T, Natori A, Hozumi J, Shimojo N, Kida K, Yamauchi H and Yamauchi T: Poor efficacy of the phosphorylated high-molecular-weight neurofilament heavy subunit serum level, a biomarker of
axonal damage, as a marker of chemotherapy-induced peripheral neuropathy. Biomed Rep 4: 758-760, 2016.
APA
Sumitani, M., Ogata, T., Natori, A., Hozumi, J., Shimojo, N., Kida, K. ... Yamauchi, T. (2016). Poor efficacy of the phosphorylated high-molecular-weight neurofilament heavy subunit serum level, a biomarker of
axonal damage, as a marker of chemotherapy-induced peripheral neuropathy. Biomedical Reports, 4, 758-760. https://doi.org/10.3892/br.2016.648
MLA
Sumitani, M., Ogata, T., Natori, A., Hozumi, J., Shimojo, N., Kida, K., Yamauchi, H., Yamauchi, T."Poor efficacy of the phosphorylated high-molecular-weight neurofilament heavy subunit serum level, a biomarker of
axonal damage, as a marker of chemotherapy-induced peripheral neuropathy". Biomedical Reports 4.6 (2016): 758-760.
Chicago
Sumitani, M., Ogata, T., Natori, A., Hozumi, J., Shimojo, N., Kida, K., Yamauchi, H., Yamauchi, T."Poor efficacy of the phosphorylated high-molecular-weight neurofilament heavy subunit serum level, a biomarker of
axonal damage, as a marker of chemotherapy-induced peripheral neuropathy". Biomedical Reports 4, no. 6 (2016): 758-760. https://doi.org/10.3892/br.2016.648
